Literature DB >> 8830954

The reliability of the diagnostic features in patients with narcolepsy.

M Folkerts1, L Rosenthal, T Roehrs, S Krstevska, A Murlidhar, F Zorick, R Wittig, T Roth.   

Abstract

This study determined the test-retest reliability of the polysomnographic findings in narcolepsy. The diagnosis of narcolepsy was based on clinical symptoms and polysomnographic signs. Control subjects were screened before participation and were split based on their screening multiple sleep latency test (MSLT) into high- and low-MSLT groups. Subjects completed two polysomnographic evaluations with at least 5 days between laboratory tests. Narcoleptics had lower sleep efficiencies and high stage 1% when compared to the low MSLT control group. They had more awakenings and less stage 2% than the control groups. Narcoleptics had a shorter latency to 1 when compared to the high-MSLT group but comparable to that of the low-MSLT group. Narcoleptics had a higher number of sleep-onset rapid eye movement periods (SOREMPs) than both control groups. The MSLT scores were stable across the two evaluations and showed a statistically significant correlation. Twenty-eight of the 30 narcoleptic subjects had two or more SOREMPs on reevaluation. None of the controls had multiple SOREMPs. Thus, multiple SOREMPs were shown to be a reliable finding in patients with narcolepsy.

Entities:  

Mesh:

Year:  1996        PMID: 8830954     DOI: 10.1016/0006-3223(95)00383-5

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  13 in total

1.  Validation of a Chinese version of the Epworth sleepiness scale.

Authors:  Ning-Hung Chen; Murray W Johns; Hseuh-Yu Li; Chia-Chen Chu; Shu-Cheng Liang; Yu-Hsiang Shu; Ming-Lung Chuang; Pa-Chun Wang
Journal:  Qual Life Res       Date:  2002-12       Impact factor: 4.147

Review 2.  [The neurology of REM sleep. A synoptic tour de force].

Authors:  N J Diederich
Journal:  Nervenarzt       Date:  2007-04       Impact factor: 1.214

3.  The MSLT: More objections than benefits as a diagnostic gold standard?

Authors:  Geert Mayer; Gert Jan Lammers
Journal:  Sleep       Date:  2014-06-01       Impact factor: 5.849

Review 4.  Central Disorders of Hypersomnolence: Focus on the Narcolepsies and Idiopathic Hypersomnia.

Authors:  Zeeshan Khan; Lynn Marie Trotti
Journal:  Chest       Date:  2015-07       Impact factor: 9.410

5.  A Longitudinal Follow-Up Study on Multiple Sleep Latency Test and Body Mass Index of Patients With Narcolepsy Type 1 in Korea.

Authors:  Yoo Hyun Um; Tae-Won Kim; Jong-Hyun Jeong; Ho-Jun Seo; Jin-Hee Han; Sung-Min Kim; Ji Hyun Song; Seung-Chul Hong
Journal:  J Clin Sleep Med       Date:  2017-12-15       Impact factor: 4.062

6.  Idiopathic hypersomnia: a study of 77 cases.

Authors:  Kirstie N Anderson; Samantha Pilsworth; Linda D Sharples; Ian E Smith; John M Shneerson
Journal:  Sleep       Date:  2007-10       Impact factor: 5.849

7.  Test-Retest Reliability of Two Consecutive Mean Sleep Latency Tests in Patients with Hypersomnia.

Authors:  Younghoon Kwon; Louis Kazaglis; Yeilim Cho; Michael J Howell; Mark W Mahowald
Journal:  Sleep Biol Rhythms       Date:  2017-08-16       Impact factor: 1.186

8.  The MSLT is Repeatable in Narcolepsy Type 1 But Not Narcolepsy Type 2: A Retrospective Patient Study.

Authors:  Chad Ruoff; Fabio Pizza; Lynn Marie Trotti; Karel Sonka; Stefano Vandi; Joseph Cheung; Swaroop Pinto; Mali Einen; Narong Simakajornboon; Fang Han; Paul Peppard; Sona Nevsimalova; Giuseppe Plazzi; David Rye; Emmanuel Mignot
Journal:  J Clin Sleep Med       Date:  2018-01-15       Impact factor: 4.062

9.  Narcolepsy and predictors of positive MSLTs in the Wisconsin Sleep Cohort.

Authors:  Aviv Goldbart; Paul Peppard; Laurel Finn; Chad M Ruoff; Jodi Barnet; Terry Young; Emmanuel Mignot
Journal:  Sleep       Date:  2014-06-01       Impact factor: 5.849

10.  Nocturnal rapid eye movement sleep latency for identifying patients with narcolepsy/hypocretin deficiency.

Authors:  Olivier Andlauer; Hyatt Moore; Laura Jouhier; Christopher Drake; Paul E Peppard; Fang Han; Seung-Chul Hong; Francesca Poli; Giuseppe Plazzi; Ruth O'Hara; Emmanuel Haffen; Thomas Roth; Terry Young; Emmanuel Mignot
Journal:  JAMA Neurol       Date:  2013-07       Impact factor: 18.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.